AlphaTime Acquisition Corp Ordinary Shares (ATMC)vsChurchill Capital Corp XI (CCXI)
ATMC
AlphaTime Acquisition Corp Ordinary Shares
$15.60
0.00%
FINANCIAL SERVICES · Cap: $38.02M
CCXI
Churchill Capital Corp XI
$13.52
-6.89%
FINANCIAL SERVICES · Cap: $805.98M
Smart Verdict
WallStSmart Research — data-driven comparison
CCXI leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 24/100 (F).
ATMC
Avoid22
out of 100
Grade: F
CCXI
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
No standout strengths identified
Areas to Watch
0.0% revenue growth
Smaller company, higher risk/reward
ROE of 3.9% — below average capital efficiency
0.0% margin — thin
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 4.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ATMC
The strongest argument for ATMC centers on Debt/Equity.
Bull Case : CCXI
CCXI has a balanced fundamental profile.
Bear Case : ATMC
The primary concerns for ATMC are Revenue Growth, Market Cap, Return on Equity. A P/E of 186.3x leaves little room for execution misses.
Bear Case : CCXI
The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
CCXI is growing revenue faster at 0.0% — sustainability is the question.
ATMC generates stronger free cash flow (-5,067), providing more financial flexibility.
Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CCXI scores higher overall (24/100 vs 22/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AlphaTime Acquisition Corp Ordinary Shares
FINANCIAL SERVICES · SHELL COMPANIES · USA
AlphaTime Acquisition Corp (ATMC) is a special purpose acquisition company (SPAC) focused on merging with high-growth, innovative firms across diverse sectors. Backed by robust capital and guided by an experienced management team, ATMC identifies transformative opportunities that enhance scalability and drive shareholder value. With a strategic approach to navigating the complexities of mergers and acquisitions, the company is positioned to deliver sustainable growth and long-term returns in a dynamic market landscape.
Churchill Capital Corp XI
FINANCIAL SERVICES · SHELL COMPANIES · USA
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
Compare with Other SHELL COMPANIES Stocks
Want to dig deeper into these stocks?